RxDoctor Payments Data

Carline Archille

Psychiatric/Mental Health · Ewing, NJNPI 1215584107

Payments from drug & device makers

$3,854in general payments, 2019–2025

Across 190 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$590
  • Lundbeck LLC$423
  • Alkermes, Inc.$390
  • Johnson & Johnson$272
  • Teva Pharmaceuticals USA, Inc.$255
  • plus $636 from 5 others

What the payments were for

  • Food & beverage$3,854100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,854 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey

Medicare billing

Part B allowed, 2024
$12,097
Medicare patients
70
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl78$111,590
Invega SustennaPaliperidone Palmitate39$84,378
LatudaLurasidone Hcl12$25,362
Lurasidone Hcl14$23,049
Aripiprazole105$14,162
Bupropion XlBupropion Hcl150$2,566
Clozapine20$2,106
Duloxetine Hcl78$2,079
Olanzapine77$1,821
Quetiapine Fumarate147$1,701
Perphenazine29$1,697
Varenicline Tartrate12$1,696
Divalproex Sodium ErDivalproex Sodium48$1,650
Ziprasidone Hcl60$1,389
Haloperidol26$1,280

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,288$111,59078 claims
Johnson & JohnsonInvega Sustenna$272$84,37839 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.

Other psychiatric/mental health in Ewing

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →